FinVector: Funding, Investors & Team (Sep 2026)
FinVector is internationally recognized for its expertise in Viral-Based Gene Therapy products with cutting-edge facilities and a skilled team of scientists. Their strong dedication to closely collaborating with clients throughout the entire process has earned them a stellar reputation in the field of gene therapy. Additionally, they are authorized by EMA to produce gene therapy products for both clinical trials and commercial distribution.
FinVector has raised $48.2M across 1 funding round on record, the most recent an undisclosed round of $48.2M announced in Jun 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
FinVector Company Profile and Key Stats
Latest funding round on record: Jun 2023.
FinVector Funding Rounds
FinVector Founders and Leadership Team
Contact details for the FinVector team: 1 of 1 has an email address on file.
Start 14-day free trial →FinVector Funding Compared to Other Biotechnology Startups
FinVector's latest round of $48.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FinVector in Biotechnology and Kuopio
Companies Similar to FinVector
Solar Foods is a food-tech startup that focuses on utilizing a technology that involves using electricity to…
Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to…
Bioretec Ltd. is a Finnish material technology company focused on the development, manufacturing and…
NPHarvest is a company with expertise in organic waste management, wastewater treatment, and nutrient…
They are a pioneering company driven by a passion for innovation and a commitment to solving their partners’…
StemSight is a startup focusing on cell therapy in Tampere, Finland, where they are working on innovative…
Herantis Pharma is a company focused on addressing medical needs that have not been met by current treatments.
Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and…
Eevia Health is a Nordic life science company based in Finland and Norway, with headquarters in Seinäjoki and…
Nexstim is a medical device company focused on image-guided transcranial magnetic stimulation, dedicated to…
Enifer is a company that specializes in using fungal fermentation to create products from byproducts of the…
FinVector Funding FAQs
What does FinVector do?
FinVector is internationally recognized for its expertise in Viral-Based Gene Therapy products with cutting-edge facilities and a skilled team of scientists. Their strong dedication to closely collaborating with clients throughout the entire process has earned them a stellar reputation in the field of gene therapy. Additionally, they are authorized by EMA to produce gene therapy products for both clinical trials and commercial distribution.
How much funding has FinVector raised?
FinVector has raised $48.2M across 1 round on record. The most recent is an undisclosed round of $48.2M announced in Jun 2023.
When did FinVector last raise funding?
FinVector's most recent funding round on record is an undisclosed round of $48.2M, announced in Jun 2023.
Who founded FinVector?
FundedIQ lists Jouko Prami (Founder) at FinVector.
Where is FinVector headquartered?
FinVector is based in Kuopio, Eastern Finland, Finland.
How many employees does FinVector have?
FinVector is in the 101-250 employee band.
How does FinVector's funding compare to other Biotechnology startups?
FinVector's latest round of $48.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's FinVector Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FinVector is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.